1Reinsmoen NL. Cellular methods used to evaluate the immune re- sponse transplantation. Tissue Antigens 2002,59:241 - 250.
2Dinavahi R, Heeger PS. T - cell immune monitoring in organ trans- plantation. Curr Opin OrganTransplant,2008,13(4) :419 -424.
3P. De paolis, A. Favaro, A. piola, et al. " Immuknow" to measu - re- merit of cell - mediated immunity in renal transplant recipients under- going short - term evaluation. Transplantation Proceedings, 2011,43 (4) :1013 - 1016.
5Kirk AD, Mannon RB, Swanson SJ, et al. Strategies for minimizing im- munosuppression in kidey transplantation. Transplant international, 2005,18( 1 ) :2 - 14.
6Batal I,Zeevi A, et al. Measurements of global cell -mediated immu- nity in renal transplant recipients with BK virus reactivation. AM J clin pathol,2008,129 (4) :587 - 591.
7A. Gautam,S. A fischer,A. F. Yango,et al. Suppression of cell -medi- ated immunity by a donor - transmitted lymphocytic choriomeningtis virus in kidney transplant recipient. Transplant infectious disease, 2007,9(4) :339 -342.
9Sindhi R, Webber SA. Preventing acute and chronic rejection after di- agnosis of post - transplantation lymphoproliferative disorder. Pediatr Transplant, 2003,7:339 - 341.
10Gautam A, Morrissey PE, Brem AS, et all. Use of an immune function assay to monitor immunosuppression for treatment of post - transplant lymphoprpliferative disorder. Pediatr transplantation, 2006, 10:613 -616.
2Moyer JD,Henders on JF.Ultrasensitive assay for ri-bonucleoside triphosphates in 50-1000 cells.application to studies with pyrazofurin and mycophenolic acid[J].Biochem Pharmacol,1983,32 (24):3831-3834.
3Sottong PR,Rosebrock JA,Britz JA,et al.Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP[J].Clin Diagn Lab Immunol,2000,7 (2):307-311.
4Buttgereit F,Burmester GR,Brand MD.Bioenergetics of immune functions:fundamental and therapeutic aspects[J].Immunol Today,2000,21 (4):192-199.
5Schulick RD,Weir MB,Miller MW,et al.Longitudinal study of in vitro CD4+ T helper cell function in recently transplanted renal allograft patients undergoing tapering of their immunosuppressive drugs[J].Transplantation,1993,56 (3):590-596.
6Kowalski R,Post D,Schneider MC,et al.Immune cell function testing:an adjunct to therapeutic drug monitoring in transplant patient management.Clin Transplant,2003,17(2):77-88.
7Gautam A,Fischer SA,Yango AF,et al.Cell mediated immunity (CMI) and post transplant viral infections-role of a functional immune assay to titrate immunosuppression.Int Immunopharmacol,2006,6(13-14):2023-2026.
8Israeli M,Klein T,Sredni B,et al.ImmuKnow:a new parameter in immune monitoring of pediatric liver transplantation recipients.Liver Tranapl,2008,14 (6):893-898.
9Bhorade SM,Janata K,Vigneswaran WT,et al.Cylex ImmuKnow assay levels are lower in lung transplant recipients with infection.J Heart Lung Transplant,2008,27 (9):990-994.
10Zeevi A,Britz JA,Bentlejewski CA,et al.Monitoring immune function during taerolimus tapering in small bowel transplant recipients.Transpl lmmunol,2005,15 (1):17-24.
